Review of the New Standard in Treatment and Global Issues: Androgen Deprivation Treatment (ADT), Chemotherapy, Androgen Receptors Inhibitors, and Androgen Synthesis Inhibitors
Marc B. Garnick, MD, Gorman Brothers Professor of Medicine at Harvard Medical School and the Beth Israel Deaconess Medical Center, reviews current literature on the treatment of prostate cancer. Dr. Garnick focuses specifically on Androgen Deprivation Therapy (ADT,) Chemotherapy, Androgen Receptor Inhibitors, and Androgen Synthesis Inhibitors.
In this presentation, Dr. Garnick explores the current landscape of Advanced Prostate Cancer Treatments, the use of triplet therapies in combating metastatic Castration-Sensitive Prostate Cancer (mCSPC), and the possibility of avoiding ADT by combining advanced imaging techniques with Metastases-Directed Therapy (MDT).
Read More